Electrophysiology testing for risk stratification of patients with ischaemic cardiomyopathy: a call for action

Area of Science:

• Cardiology
• Electrophysiology
• Medical Guidelines

Background:

• Current guidelines recommend implantable cardioverter defibrillator (ICD) therapy for primary prevention of sudden cardiac death (SCD).
• These recommendations rely solely on left ventricular ejection fraction (LVEF) as the criterion for ICD indication.
• The predictive value of LVEF for different causes of cardiac death requires further examination.

Purpose of the Study:

• To review the diagnostic accuracy of LVEF in predicting arrhythmic versus non-arrhythmic cardiac death.
• To evaluate the utility of electrophysiology testing for risk stratification in ischemic patients with reduced left ventricular function.

Main Methods:

• Systematic review of primary sudden cardiac death prevention trials.
• Analysis of the sensitivity and specificity of LVEF for predicting cardiac death outcomes.
• Examination of existing evidence on electrophysiology testing in risk stratification.

Main Results:

• Left ventricular ejection fraction (LVEF) has limitations in distinguishing between arrhythmic and non-arrhythmic cardiac death.
• Electrophysiology testing may offer additional value in risk stratification for specific patient groups.
• Evidence suggests LVEF alone may not be sufficient for comprehensive risk assessment.

Conclusions:

• Relying solely on LVEF for primary prevention ICD decisions may not be optimal.
• Electrophysiology testing warrants consideration for refining risk stratification in ischemic patients with reduced LVEF.
• Further research is needed to establish comprehensive criteria for ICD implantation.